(Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug ...

Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...

An experimental treatment method has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus ...

A cancer-drug combination from Merck, Pfizer and Astellas Pharma has hit a key goal in a late-stage study in patients with a hard-to-treat form of bladder cancer. The companies on Tuesday said Merck's ...

Deion Sanders was "unashamed" to open up about the effects of his bladder removal surgery in a new interview with Good Morning America. In June, the NFL legend and current Colorado Buffaloes coach ...

Credit: Johnson & Johnson. Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet. Inlexzo is an intravesical gemcitabine ...